Literature DB >> 23564577

Complement in immune and inflammatory disorders: pathophysiological mechanisms.

Daniel Ricklin1, John D Lambris.   

Abstract

Although acute or chronic inflammation is a common component of many clinical disorders, the underlying processes can be highly distinct. In recent years, the complement system has been associated with a growing number of immunological and inflammatory conditions that include degenerative diseases, cancer, and transplant rejection. It becomes evident that excessive activation or insufficient control of complement activation on host cells can cause an immune imbalance that may fuel a vicious cycle between complement, inflammatory cells, and tissue damage that exacerbates clinical complications. Although the exact involvement of complement needs to be carefully investigated for each disease, therapeutic modulation of complement activity emerges as an attractive target for upstream inhibition of inflammatory processes. This review provides an update about the functional and collaborative capabilities of complement, highlights major disease areas with known complement contribution, and indicates the potential for complement as a focal point in immunomodulatory strategies for treating inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564577      PMCID: PMC3623009          DOI: 10.4049/jimmunol.1203487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

Review 1.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

Authors:  D Hourcade; M K Liszewski; M Krych-Goldberg; J P Atkinson
Journal:  Immunopharmacology       Date:  2000-08

2.  A critical role for C5L2 in the pathogenesis of experimental allergic asthma.

Authors:  Xun Zhang; Inken Schmudde; Yves Laumonnier; Manoj K Pandey; Jennifer R Clark; Peter König; Norma P Gerard; Craig Gerard; Marsha Wills-Karp; Jörg Köhl
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

3.  Immunology. The new view of complement.

Authors:  Mitch Leslie
Journal:  Science       Date:  2012-08-31       Impact factor: 47.728

Review 4.  The tick-over theory revisited: is C3 a contact-activated protein?

Authors:  Bo Nilsson; Kristina Nilsson Ekdahl
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

5.  C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients.

Authors:  R P Rother; J Arp; J Jiang; W Ge; S J Faas; W Liu; D R Gies; A M Jevnikar; B Garcia; H Wang
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

Review 6.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors:  Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

Review 7.  Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.

Authors:  Hydar Ali
Journal:  Immunol Lett       Date:  2009-11-04       Impact factor: 3.685

Review 8.  Regulation of humoral immunity by complement.

Authors:  Michael C Carroll; David E Isenman
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

Review 9.  Complement in immune and inflammatory disorders: therapeutic interventions.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

Review 10.  Complement activation and cardiac surgery: a novel target for improving outcomes.

Authors:  Gregory L Stahl; Stanton K Shernan; Peter K Smith; Jerrold H Levy
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

View more
  184 in total

1.  The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Authors:  Masha Fridkis-Hareli; Michael Storek; Eran Or; Richard Altman; Suresh Katti; Fang Sun; Tao Peng; Jeff Hunter; Krista Johnson; Yi Wang; Ante S Lundberg; Gaurav Mehta; Nirmal K Banda; V Michael Holers
Journal:  Mol Immunol       Date:  2018-12-01       Impact factor: 4.407

Review 2.  The emerging role of complement inhibitors in transplantation.

Authors:  Véronique Frémeaux-Bacchi; Christophe M Legendre
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

3.  TMA: beware of complements.

Authors:  Daniel Ricklin; Douglas B Cines
Journal:  Blood       Date:  2013-09-19       Impact factor: 22.113

4.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

5.  A novel method for direct measurement of complement convertases activity in human serum.

Authors:  A M Blom; E B Volokhina; V Fransson; P Strömberg; L Berghard; M Viktorelius; T E Mollnes; M López-Trascasa; L P van den Heuvel; T H Goodship; K J Marchbank; M Okroj
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.

Authors:  Cynthia Owsley; Carrie Huisingh; Gregory R Jackson; Christine A Curcio; Alexander J Szalai; Nassrin Dashti; Mark Clark; Kia Rookard; Mark A McCrory; Tyler T Wright; Michael A Callahan; Lanning B Kline; C Douglas Witherspoon; Gerald McGwin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

Review 7.  From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; George Hajishengallis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2016-06-16       Impact factor: 3.144

8.  Terminal complement complex formation is associated with intervertebral disc degeneration.

Authors:  Graciosa Q Teixeira; Zhiyao Yong; Raquel M Goncalves; Amelie Kuhn; Jana Riegger; Helena Brisby; Helena Barreto Henriksson; Michael Ruf; Andreas Nerlich; Uwe M Mauer; Anita Ignatius; Rolf E Brenner; Cornelia Neidlinger-Wilke
Journal:  Eur Spine J       Date:  2020-09-16       Impact factor: 3.134

Review 9.  Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.

Authors:  Julian K Horwitz; Nicholas H Chun; Peter S Heeger
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

Review 10.  The dual role of complement in cancer and its implication in anti-tumor therapy.

Authors:  Ioannis Kourtzelis; Stavros Rafail
Journal:  Ann Transl Med       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.